-
1
-
-
18744388266
-
Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group
-
DOI 10.1038/sj.tpj.6500131
-
Anderson, D.C. et al.; pharmacogenetics Working Group. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J. 2, 284-292 (2002). (Pubitemid 35452485)
-
(2002)
Pharmacogenomics Journal
, vol.2
, Issue.5
, pp. 284-292
-
-
Anderson, D.C.1
Gomez-Mancilla, B.2
Spear, B.B.3
Barnes, D.M.4
Cheeseman, K.5
Shaw, P.M.6
Friedman, J.7
McCarthy, A.8
Brazell, C.9
Ray, S.C.10
McHale, D.11
Hashimoto, L.12
Sandbrink, R.13
Watson, M.L.14
Salerno, R.A.15
Cohen, N.16
Lister, C.E.17
-
2
-
-
40049095337
-
A proposal for a model of informed consent for the collection, Storage and use of biological materials for research purposes
-
Porteri, C. & Borry, P. A proposal for a model of informed consent for the collection, Storage and use of biological materials for research purposes. Patient Educ. Couns. 71, 136-142 (2008).
-
(2008)
Patient Educ. Couns.
, vol.71
, pp. 136-142
-
-
Porteri, C.1
Borry, P.2
-
3
-
-
28644448646
-
Terminology for sample collection in clinical genetic studies
-
pharmacogenetics Working Group
-
Spear, B.B. et al.; pharmacogenetics Working Group. Terminology for sample collection in clinical genetic studies. Pharmacogenomics J. 1, 101-103 (2001)
-
(2001)
Pharmacogenomics J.
, vol.1
, pp. 101-103
-
-
Spear, B.B.1
-
5
-
-
79952984875
-
Challenges in conducting clinical research trials in emerging market economies
-
Roohi, F.H. Challenges in conducting clinical research trials in emerging market economies. Monitor 23, 31-35 (2009).
-
(2009)
Monitor
, vol.23
, pp. 31-35
-
-
Roohi, F.H.1
-
6
-
-
79952989340
-
Successful start of clinical trials in israel: A roadmap for pharmaceutical and medical device trials
-
Koren, A. Successful start of clinical trials in israel: a roadmap for pharmaceutical and medical device trials. Monitor 21, 57-61 (2007).
-
(2007)
Monitor
, vol.21
, pp. 57-61
-
-
Koren, A.1
-
7
-
-
79952991774
-
The current regulatory environment for clinical research in india
-
Gupta, S.K. The current regulatory environment for clinical research in india. Monitor 23, 27-29 (2009).
-
(2009)
Monitor
, vol.23
, pp. 27-29
-
-
Gupta, S.K.1
-
8
-
-
79952984661
-
Conducting global clinical trials in asia
-
Huang, G., Xu, Q., Zang, L., Halloran, L.A. & Zhong, J.Q. Conducting global clinical trials in asia. Monitor 23, 42-46 (2009).
-
(2009)
Monitor
, vol.23
, pp. 42-46
-
-
Huang, G.1
Xu, Q.2
Zang, L.3
Halloran, L.A.4
Zhong, J.Q.5
-
9
-
-
79952984928
-
International clinical trials in Russia: An insider's perspective
-
Storozhuk, E., Khabriev, R.U. & Filunin, S.V. International clinical trials in Russia: an insider's perspective. Monitor 21, 35-39 (2007).
-
(2007)
Monitor
, vol.21
, pp. 35-39
-
-
Storozhuk, E.1
Khabriev, R.U.2
Filunin, S.V.3
-
10
-
-
33646254125
-
Reporting genetic results in research studies: Summary and recommendations of an NHLBi working group
-
NHLBi Working Group
-
Bookman, E.B. et al.; NHLBi Working Group. Reporting genetic results in research studies: summary and recommendations of an NHLBi working group. Am. J. Med. Genet. A 140, 1033-1040 (2006).
-
(2006)
Am. J. Med. Genet. A
, vol.140
, pp. 1033-1040
-
-
Bookman, E.B.1
-
11
-
-
31644440090
-
Returning genetic research results to individuals: Points-to-consider
-
DOI 10.1111/j.1467-8519.2006.00473.x
-
Renegar, G. et al. Returning genetic research results to individuals: points-to-consider. Bioethics 20, 24-36 (2006). (Pubitemid 43168271)
-
(2006)
Bioethics
, vol.20
, Issue.1
, pp. 24-36
-
-
Renegar, G.1
Webster, C.J.2
Stuerzebecher, S.3
Harty, L.4
Ide, S.E.5
Balkite, B.6
Rogalski-Salter, T.A.7
Cohen, N.8
Spear, B.B.9
Barnes, D.M.10
Brazell, C.11
-
12
-
-
79952994279
-
Coding of DNa samples and data in the pharmaceutical industry: Current practices and future directions
-
Franc, M.A., Cohen, N., Warner, A.W., Shaw, P.M., Groenen, P. & Snapir, A. Coding of DNa samples and data in the pharmaceutical industry: current practices and future directions. Clin. Pharm. Ther. 89, 537-545 (2011).
-
(2011)
Clin. Pharm. Ther.
, vol.89
, pp. 537-545
-
-
Franc, M.A.1
Cohen, N.2
Warner, A.W.3
Shaw, P.M.4
Groenen, P.5
Snapir, A.6
-
14
-
-
79952991837
-
Challenges in obtaining adequate genetic sample sets in clinical trials: The perspective of the industry pharmacogenomics Working Group
-
Warner, A.W. et al. Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the industry pharmacogenomics Working Group. Clin. Pharm. Ther. 89, 529-536 (2011).
-
(2011)
Clin. Pharm. Ther.
, vol.89
, pp. 529-536
-
-
Warner, A.W.1
-
17
-
-
79952993123
-
Current practices for DNa sample collection and storage in the pharmaceutical industry, and potential areas for harmonization
-
Franc, M.A., Warner, A.W., Cohen, N., Shaw, P.M., Groenen, P. & Snapir, A. Current practices for DNa sample collection and storage in the pharmaceutical industry, And potential areas for harmonization. Clin. Pharm. Ther. 89, 546-553 (2011).
-
(2011)
Clin. Pharm. Ther.
, vol.89
, pp. 546-553
-
-
Franc, M.A.1
Warner, A.W.2
Cohen, N.3
Shaw, P.M.4
Groenen, P.5
Snapir, A.6
-
18
-
-
80052667893
-
-
US Food and Drug administration
-
US Food and Drug administration. Meeting of advisory Committee for pharmaceutical Science and Clinical pharmacology. http://www.Fda.Gov/downloads/ advisoryCommittees/CommitteesMeetingMaterials/Drugs/ advisoryCommitteeforpharmaceuticalScienceandClinicalpharmacology/ UCM210803.Pdf (2010).
-
(2010)
Meeting of Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
-
-
-
19
-
-
79951480123
-
-
R Development Core Team R Foundation for Statistical Computing Vienna Austria
-
R Development Core Team. R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.Org/ (2010).
-
(2010)
R: A Language and Environment for Statistical Computing
-
-
|